Heat Biologics is Biotechnology in United States that focus on Heat Biologics Inc business. Founded in 2008. They cover business area such as Heat Biologics Inc, therapy, cancer, an engineer form, Immune Pan-Antigen Cytotoxic Therapy, impact, Combination Pan-Antigen Cytotoxic Therapy, (ComPACT, its product candidate, ImPACT, tumour-associate antigen, an immune response stimulator, ligand fusion protein, co-stimulatory receptor.
2008
( 16 years old in 2024 )
Heat Biologics Inc
-
627 Davis Drive
Suite 400
Morrisville, NC 27560
United States
Private
Heat Biologics Inctherapycanceran engineer formImmune Pan-Antigen Cytotoxic TherapyimpactCombination Pan-Antigen Cytotoxic Therapy(ComPACTits product candidateImPACTtumour-associate antigenan immune response stimulatorligand fusion proteinco-stimulatory receptor
* We use standard office opening hours in near Heat Biologics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Heat Biologics is Biotechnology business from United States that founded in 2008 (16 years old in 2024), Heat Biologics business is focusing on Heat Biologics Inc.
Heat Biologics headquarter office and corporate office address is located in 627 Davis Drive Suite 400 Morrisville, NC 27560 United States.
Heat Biologics was founded in United States.
In 2024, Heat Biologics is currently focus on Heat Biologics Inc sector.
Above is snippet of Google Trends for "Heat Biologics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Heat Biologics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
